PATENT CLAIM ANALYSIS

Application Number: 16056613
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["424", "465000"]

Abstract:
Solid pharmaceutical dosage form for the release of at least one Active Pharmaceutical Ingredient (API) in the oral cavity comprising a core coated by at least one film coating. The core comprises at least one API. One or more organoleptically disturbing sensations induced by one or several of the APIs and/or of inactive components of the solid pharmaceutical dosage form is/are reduced by constituents of said film coating. Said constituents comprise at least one film-forming polymer and at least one flavoring agent or at least one sweetener.

Claim (Index 31):
The method of administering a lozenge according to  claim 27  wherein upon administration said API is absorbable by the mucosa of the oral cavity and/or by the mucosa of the pharynx.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 96.0
- Lexical Diversity: 1.69091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12057177', '11223819', '15879740', '15387317', '15852486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7511119853335089
- 35 USC 102 Novelty (BERT): 0.5057110222893952
- Combined Prediction Score: 0.7265718890290975
- Mean Citation Score: 222.17800400000004
- Max Citation Score: 235.37862
- Similarity Product: 149.64536586200953

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test